Piper Jaffray Cos. covered Tactile Systems Technology Inc (NASDAQ:TCMD), stepping up its price target to $17.00 earlier today
- Updated: September 17, 2016
Indicating a possible upside of 0.28%, Piper Jaffray Cos. upped the estimated target of Tactile Systems Technology Inc (NASDAQ:TCMD) to $17.
Yesterday Tactile Systems Technology Inc (NASDAQ:TCMD) traded 4.61% higher at $13.24. TCMD’s 50-day moving average is $13.93 and its two hundred day moving average is $13.93. With the last close down 40.08% relative to the 200-day average, compared with the Standard & Poor’s 500 Index which has decreased -0.01% over the same time period. Trade volume was was up over the average, with 255,001 shares of TCMD changing hands over the typical 117,782 shares..
Recent Performance Chart:
With a market capitalization of $0.0, Tactile Systems Technology Inc has a P/E of 315 with a 52 week low of $10.00 and a 52 week high of $20.05.
General Company Details For Tactile Systems Technology Inc (NASDAQ:TCMD)
Tactile Systems Technology, Inc. is a United States-based medical technology company. The Company develops and provides medical devices for the treatment of chronic diseases at home. The Company markets its Flexitouch, ACTitouch and Entre systems, as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. Its Flexitouch System is a fully-automated, programmable, advanced pneumatic compression device, which is designed for treatment of lymphedema in the home setting. Its Flexitouch System consists of an electronic controller unit that offers over 10 treatment settings and multiple contoured garment configurations for the trunk and the arm or leg. Its ACTitouch System consists of a compression sleeve, a control unit, an undersock and a power adapter or charger. Its Entre System is a basic pneumatic compression device used for the at-home treatment of venous disorders, including lymphedema and chronic venous insufficiency, and including venous leg ulcers.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.